JPS57122068A - N-pyrimidinyl-carbamic acid ester, manufacture and medicine containing same - Google Patents

N-pyrimidinyl-carbamic acid ester, manufacture and medicine containing same

Info

Publication number
JPS57122068A
JPS57122068A JP56188504A JP18850481A JPS57122068A JP S57122068 A JPS57122068 A JP S57122068A JP 56188504 A JP56188504 A JP 56188504A JP 18850481 A JP18850481 A JP 18850481A JP S57122068 A JPS57122068 A JP S57122068A
Authority
JP
Japan
Prior art keywords
pyrimidinyl
manufacture
acid ester
carbamic acid
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56188504A
Other languages
English (en)
Inventor
Shiyaarubuehitaa Peetaa
Gutsuchie Kurausu
Koor Furiidoritsuhiiuiruherumu
Betsuku Hinritsuhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of JPS57122068A publication Critical patent/JPS57122068A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP56188504A 1980-12-04 1981-11-26 N-pyrimidinyl-carbamic acid ester, manufacture and medicine containing same Pending JPS57122068A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803045720 DE3045720A1 (de) 1980-12-04 1980-12-04 N-pyrimidinyl-carbaminsaeureester, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
JPS57122068A true JPS57122068A (en) 1982-07-29

Family

ID=6118292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56188504A Pending JPS57122068A (en) 1980-12-04 1981-11-26 N-pyrimidinyl-carbamic acid ester, manufacture and medicine containing same

Country Status (12)

Country Link
US (1) US4386084A (ja)
EP (1) EP0053695A3 (ja)
JP (1) JPS57122068A (ja)
AU (1) AU7821981A (ja)
DE (1) DE3045720A1 (ja)
DK (1) DK535781A (ja)
ES (1) ES8300099A1 (ja)
FI (1) FI813845L (ja)
GR (1) GR75115B (ja)
NO (1) NO814138L (ja)
PT (1) PT74077B (ja)
ZA (1) ZA818370B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005535662A (ja) * 2002-07-02 2005-11-24 サザン リサーチ インスティチュート FtsZの阻害剤およびそれらの用途

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
DK1725540T5 (da) 2004-03-05 2012-10-22 Hoffmann La Roche Diaminopyrimidiner som p2x3- og p2x2/3-antagonister
EP1924566B1 (en) * 2005-09-01 2016-01-13 F.Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators
CA2619919C (en) * 2005-09-01 2014-04-01 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators
CN101253159B (zh) * 2005-09-01 2011-12-07 弗·哈夫曼-拉罗切有限公司 作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919229A (en) * 1973-07-19 1975-11-11 Labaz Pyrimidine derivatives and process for preparing the same
BE850974A (fr) * 1977-02-01 1977-05-31 Andreu Sa Dr Nouveaux imides de trimethoprim et leur obtention
DE2709634A1 (de) * 1977-03-05 1978-09-07 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2730468A1 (de) * 1977-07-06 1979-01-18 Basf Ag Neue n-pyrimidinyl-imidsaeureester, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2730467A1 (de) * 1977-07-06 1979-01-18 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2732029A1 (de) * 1977-07-15 1979-02-01 Basf Ag Neue amidino-benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005535662A (ja) * 2002-07-02 2005-11-24 サザン リサーチ インスティチュート FtsZの阻害剤およびそれらの用途

Also Published As

Publication number Publication date
FI813845L (fi) 1982-06-05
EP0053695A3 (de) 1982-12-15
US4386084A (en) 1983-05-31
ES507682A0 (es) 1982-10-01
ZA818370B (en) 1982-11-24
AU7821981A (en) 1982-06-10
DE3045720A1 (de) 1982-07-08
EP0053695A2 (de) 1982-06-16
PT74077B (de) 1983-05-11
ES8300099A1 (es) 1982-10-01
PT74077A (de) 1982-01-01
DK535781A (da) 1982-06-05
NO814138L (no) 1982-06-07
GR75115B (ja) 1984-07-13

Similar Documents

Publication Publication Date Title
JPS5753449A (en) 2-hydroxy-5-phenylazobenzoic acid derivative, manufacture and medicinal composition
JPS5791921A (en) Medicine and manufacture
JPS5750913A (en) Nifedipin-containing solid medicine and manufacture
JPS5718671A (en) Aminocyclopentane alkenoic acid and esters thereof,manufacture and drug composition
JPS5798281A (en) Azabicyclooctane-carboxylic acid, manufacture and pharmaceutical composition containing same
PH21847A (en) Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them
JPS5781465A (en) 2-amino-3-carbethoxyamino-6-(p-fluoro- benzylamino)-pyridine-maleate, manufacture and antiinflammatory and analgesic medicine containing same
JPS5753473A (en) Novel n-aryl-2-oxazolidinones, manufacture and drug containing them
JPS5718624A (en) Drug and manufacture
GB2071665B (en) 18-glycyrrhizinic acid
IL62912A0 (en) Penam-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
JPS57123190A (en) Novel esters, manufacture and medicine containing same
JPS5780387A (en) Penicillanic acid penicillanoyloxymethyl- 1,1,1',1'-tetraoxide and manufacture
JPS56150012A (en) Isotomic solution medicine
JPS57122068A (en) N-pyrimidinyl-carbamic acid ester, manufacture and medicine containing same
JPS57120526A (en) Medicine containing kallikrein and manufacture
IL64308A0 (en) 5-amino-1-phenylpyrazole-4-carboxylic acid esters,their manufacture and their use as herbicides
JPS5782394A (en) Novel phosphorous acid ester containing hydroxyphenyl group, manufacture and use
JPS5770873A (en) Novel diaryl-imidazole compound, manufacture, pharmaceutical medicine containing same and application thereof
JPS5785367A (en) Omega-fluorosulfate-perfluorocarboxylic acid derivative and manufacture
JPS5753429A (en) 1-methyl-2-chlorocyclopropane carboxylic acid, ester thereof and manufacture
JPS56127330A (en) Novel propanoic acid derivative, manufacture and medicinal composition
JPS56154446A (en) Novel derivative of 2-amino-phenethylamine, its manufacture and novel medicine containing it
JPS5738784A (en) Penicillin derivative, manufacture and medicinal composition containing it
JPS57123200A (en) Aminopapulacandin derivative, manufacture and medicine containing same